BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Raclopride

A substituted benzamide that has antipsychotic properties. It is a dopamine D2 receptor (see RECEPTORS, DOPAMINE D2) antagonist.

300+ PubMed studies analyzed · 10 RCTs · Evidence Score: 49.4

Research Domains

Raclopride has been studied across 15 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, ⏳ Longevity & Aging, 🧠 Neuroprotection, 🧘 Stress & Anxiety. The primary research focus is 🌤️ Mood & Depression with 89% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Raclopride, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ropinirole
7 shared targets
canadine
5 shared targets
fauc
5 shared targets
cariprazine
7 shared targets
bdb
5 shared targets
stepholidine
5 shared targets
quinpirole
5 shared targets
ecopipam
4 shared targets
zotepine
6 shared targets
dopamine
4 shared targets
Loading evidence profile...

This evidence profile for Raclopride is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.